Headquartered in Australia, Zelda Therapeutics Limited (ASX: ZLD) develops cannabinoid -based medicines to treat human diseases and disorders. Read More
The post Zelda Receives Cash Refund Of $769000 Under R&D Tax Incentive Scheme appeared first on Dagga Magazine.